Dr. Hannah Wingate, associate professor of Biology, along with collaborators from The University of Texas MD Anderson Cancer Center, published an article describing the use of a novel marker to predict response of breast cancer patients to chemotherapeutic treatment. The paper, entitled, “Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer,” was published in the August 2019 issue of the Annals of Surgery.